Search
To take advantage of the growing field of nanotechnology, Memorial Sloan Kettering has established a Nanotechnology Center.
A new project called the BRCA Exchange is sharing data about BRCA mutations and what they actually mean for cancer risk.
A protein detected in the urine of children with Wilms’ tumor led to the development of a test to improve diagnosis and treatment.
Watch our scientists discuss how the Geoffrey Beene Center helped Memorial Sloan Kettering establish a progressive approach to modern cancer research.
Johanna Joyce, of the Sloan Kettering Institute's Cancer Biology and Genetics Program, has been named the first incumbent of a Geoffrey Beene Junior Faculty Chair.
Long-awaited results of clinical trials testing targeted drugs and immunotherapy combinations were on offer at the annual American Association for Cancer Research (AACR) conference.
The 2023 GSK Chairman’s Prize recognizes Chi Nguyen for research on gut health.
Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is widely recognized as someone who is revolutionizing the molecular treatment of cancer.
Physician-scientist Charles Sawyers played a pivotal role in the development of Gleevec, one of the first successful targeted drugs for cancer.
The high-resolution views provided by cryo-electron microscopy are helping scientists learn how proteins and DNA collaborate to repair broken DNA.